Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rector

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Circulation. Heart Failure|January 24, 2012
Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trialThomas S Rector, Peter E Carson, Inder S Anand, et al.
European Journal of Clinical Nutrition|December 23, 2011
Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese womenP S Hinton, R S Rector, M A Linden, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 12, 2016
Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat dietMatthew R Panasevich, E M Morris, S V Chintapalli, et al.
Journal of Cardiac Failure|June 11, 2005
Clinical and analytical considerations in the study of health status in device trials for heart failureSharon-Lise T Normand, Thomas S Rector, James D Neaton, et al.
Circulation. Heart Failure|September 17, 2014
History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fractionOludamilola W Oluleye, Thomas S Rector, Sithu Win, et al.
Immunology|December 1, 1984
Immunochemical properties of some monoclonal IgE antibodies to 4-hydroxy-3-nitrophenylacetyl (NP)R Bose, P G Bundesen, V Holford-Stevens, et al.
Journal of the American College of Cardiology|January 9, 2007
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure TrialInder S Anand, S William Tam, Thomas S Rector, et al.
Stroke|April 6, 2002
Occurrence of secondary ischemic events among persons with atherosclerotic vascular diseaseBarbara G Vickrey, Thomas S Rector, Steven L Wickstrom, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 26, 2004
Direct medical costs attributable to acute myocardial infarction and ischemic stroke in cohorts with atherosclerotic conditionsElizabeth M Sloss, Steven L Wickstrom, Daniel F McCaffrey, et al.
Journal of Cellular Physiology|May 11, 2019
RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferationSrinivas Mummidi, Nitin A Das, Andrea J Carpenter, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Circulation. Heart Failure|January 24, 2012
Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trialThomas S Rector, Peter E Carson, Inder S Anand, et al.
European Journal of Clinical Nutrition|December 23, 2011
Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese womenP S Hinton, R S Rector, M A Linden, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 12, 2016
Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat dietMatthew R Panasevich, E M Morris, S V Chintapalli, et al.
Journal of Cardiac Failure|June 11, 2005
Clinical and analytical considerations in the study of health status in device trials for heart failureSharon-Lise T Normand, Thomas S Rector, James D Neaton, et al.
Circulation. Heart Failure|September 17, 2014
History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fractionOludamilola W Oluleye, Thomas S Rector, Sithu Win, et al.
Immunology|December 1, 1984
Immunochemical properties of some monoclonal IgE antibodies to 4-hydroxy-3-nitrophenylacetyl (NP)R Bose, P G Bundesen, V Holford-Stevens, et al.
Journal of the American College of Cardiology|January 9, 2007
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure TrialInder S Anand, S William Tam, Thomas S Rector, et al.
Stroke|April 6, 2002
Occurrence of secondary ischemic events among persons with atherosclerotic vascular diseaseBarbara G Vickrey, Thomas S Rector, Steven L Wickstrom, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 26, 2004
Direct medical costs attributable to acute myocardial infarction and ischemic stroke in cohorts with atherosclerotic conditionsElizabeth M Sloss, Steven L Wickstrom, Daniel F McCaffrey, et al.
Journal of Cellular Physiology|May 11, 2019
RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferationSrinivas Mummidi, Nitin A Das, Andrea J Carpenter, et al.
Pageof 16